These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8763063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS.
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
    Gournay J, Richou C.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Current state of interferon therapy in the treatment of chronic hepatitis B.
    Manns MP.
    Semin Liver Dis; 2002 Apr; 22 Suppl 1():7-13. PubMed ID: 12447724
    [Abstract] [Full Text] [Related]

  • 7. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M, Constant T, Monges D, Djaghri N, Angeli-Besson C, Gerolami A.
    Gastroenterol Clin Biol; 1994 Apr; 18(11):1051. PubMed ID: 7705576
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH, Dickson RC, Post AB, Redfield RR, Davis GL, Neumann AU, Osborn BL, Freimuth WW, Subramanian GM.
    Antivir Ther; 2006 Apr; 11(1):35-45. PubMed ID: 16518958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [Abstract] [Full Text] [Related]

  • 17. Interferon-alpha. Amarillo Biosciences.
    Barnard DL.
    Curr Opin Investig Drugs; 2002 May; 3(5):693-7. PubMed ID: 12090541
    [Abstract] [Full Text] [Related]

  • 18. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA, Khawaja FI, Mahrous AR.
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V, Toccaceli F, Rosati S, Monini A, Grimaldi M, Foglianti G, Canova N, Palazzini E.
    Hepatogastroenterology; 1997 Apr; 44(16):1182-6. PubMed ID: 9261621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.